Santen Pharmaceutical Co (JP:4536) has released an update.
Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 93,391 treasury shares at 1,623.5 yen per share on July 22, 2024, following a resolution by its Board of Directors. A total of 151,620,288.5 yen was raised through this disposal, which was allotted among 4 Directors and 10 Corporate Officers. This move is part of the company’s Restricted Stock-Linked Remuneration Program aimed at incentivizing its leadership team.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
